A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Quadriga Biosciences, Inc.
Xencor, Inc.
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)